Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: 52 Week Safety and Efficacy in an Open-Label, Long-Term Extension Study Baker, M., Chalabi, Y., Genovese, M., Taylor, P., Schlichting, D., Beattie, S., Macias, W., Keystone, E. J RHEUMATOL PUBL CO. 2014: 1505
View details for Web of Science ID 000338923700160